When to upgrade
With a new sound processor, adults and children can enjoy the benefits of the latest hearing technology. Learn more about when to consider a next-generation device.
What you'll find on this page
- An overview of when to upgrade a current sound processor
- The key benefits of upgrading
- What to do the sound processor is lost or damaged
When should an individual upgrade their sound processor?
As adults and children progress through life, their hearing needs may change with their circumstances. Whether they’re studying or navigating the workplace, juggling family, or planning for retirement, a new sound processor can help improve their hearing experience so they can get the most out of each stage of life.
To find out if a new sound processor can better meet their hearing or lifestyle needs, it is recommended to speak to a hearing health professional.
Our passion for CochlearTM sound processor recipients' progress drives us to continually innovate our sound processors to better meet their needs now and into the future.
With advances in hearing technology and features like ForwardFocus†, a next-generation sound processor is designed to provide clearer sound, even in noisy environments.1,2 New features can provide easier ways to connect with others online, on the phone and in person.
A smaller, more comfortable design, improvements in battery life and accessories like the Aqua+ are more great reasons to consider a sound processor upgrade.
A lost or irreparably damaged sound processor can be stressful, but there are options to get adults and children hearing again. If a replacement device is no longer available, they may choose to upgrade to a next-generation sound processor. Our latest sound processors come with improved hearing technology and additional features, as well as a new global warranty.
The ‘Find my processor’ feature in the Nucleus® Smart App can help recipients locate their misplaced device via a compatible smartphone*.
As technology progresses, sourcing parts for the manufacture, service and repair of older sound processors becomes increasingly difficult. Next-generation sound processors not only work with recipients' existing implant,** but they offer more advanced technology to help them hear more clearly and better connect with what they love.
Learn more about upgrading your device
If you're ready to upgrade — or just beginning to explore next-generation technology, choose your device type here to learn more.
“The improvements from one model to the next are very noticeable… there is an incredible improvement in the audio quality.”
- Felipe, Cochlear™ Baha® System recipient
You’ll be surprised how much a next-generation sound processor can improve your hearing – and your life.
Hear the difference. Feel the difference.
This content is intended for professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
† ForwardFocus is clinician-enabled within the Custom Sound Pro fitting software and can be user-controlled with the Cochlear Nucleus Smart App. In the Nucleus 8 Sound Processor, ForwardFocus is also available as an automated program. It is only available with the Cochlear Nucleus® 7, Nucleus 8 and Kanso® 2 sound processors.
* For information regarding the compatibility of Cochlear’s sound processors with Apple or Android devices, visit www.cochlear.com/compatibility.
** Nucleus 8 and Kanso sound processors are not compatible with the Nucleus 22 (N22) Implant.
Cochlear, Hear now. And always, Nucleus, Kanso, Baha and the elliptical logo are either trademarks or registered trademarks of Cochlear Bone Anchored Solutions AB or Cochlear Limited.
- Cochlear Limited D1376556 Acceptance and Performance with the Nucleus 7 Cochlear Implant System with Adult Recipients (2020 Jan).
- Cochlear Limited. D1817793. CLTD5754 Clinical Investigation Report (2022 Jul).